Pruritic dermatoses: overview of etiology and therapy (Q30049224)

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

author name string

Ernest N Charlesworth

series ordinal

1

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

Vincent S Beltrani

series ordinal

2

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

language of work or name

English

0 references

publication date

December 2002

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

American Journal of Medicine

25 May 2017

published in

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

volume

113

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

issue

9

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

25 May 2017

page(s)

25-33

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1

How should we define itching?

25 May 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Pain mechanisms: a new theory

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Skin reactions and itch sensation induced by epicutaneous histamine application in atopic dermatitis and controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Psychophysical Studies of the Itch Sensation and Itchy Skin (“Alloknesis”) Produced by Intracutaneous Injection of Histamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Itch: role of prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Pruritus and proteolytic enzymes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumour necrosis factor-alpha) at the dermal-epidermal junction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Local effects of synthetic leukotrienes (LTC4, LTD4, LTE4, and LTB4) in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Clinical and biochemical effects of zileuton in patients with the Sjögren-Larsson syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Opiates, mast cells and histamine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Potentiation of histamine-induced itch and flare responses in human skin by the enkephalin analogue FK 33-824, ?-endorphin and morphine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Itching and the atopic skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Disease management of atopic dermatitis: a practice parameter. Joint Task Force on Practice Parameters, representing the American Academy of Allergy, Asthma and Immunology, the American College of Allergy, Asthma and Immunology, and the Joint Counci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

In vivo studies of mediator release in cold urticaria and cholinergic urticaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Assessment of tissue fluid histamine levels in patients with urticaria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

The pathogenesis of chronic idiopathic urticaria: new evidence suggests an auto-immune basis and implications for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Urticaria and angioedema: a clinical spectrum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Cutaneous IgE‐mediated inflammatory lesion size is inhibited by an H1 antagonist (terfenadine) while mediator release is unaffected in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

The treatment of mastocytosis: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Treatment of pruritus of cholestasis by plasma perfusion through USP-charcoal-coated glass beads

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Uraemia and mast-cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Elevated Plasma Histamine in Chronic Uremia Effects of Ketotifen on Pruritus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

The pruritus of cholestasis and the opioid system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Aquagenic pruritus and the myelodysplastic syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Identification of IgA subclasses in skin of dermatitis herpetiformis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Crotamiton lotion in pruritus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Crotamiton and narrow-band UVB phototherapy: novel approaches to alleviate pruritus of breast carcinoma skin infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Effect of topical pramoxine on experimentally induced pruritus in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Effect of topical capsaicin on the cutaneous reactions and itching to histamine in atopic eczema compared to healthy skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Safety and pharmacokinetics of EMLA in the treatment of postburn pruritus in pediatric patients: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Antipruritic and thermal sensation effects of hydrocortisone creams in human skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Unapproved dermatologic indications for H2 receptor antagonists, cromolyn sodium, and ketotifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Oral disodium cromoglycate in the treatment of systemic mastocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Transcutaneous electronic nerve stimulation in the treatment of generalized pruritus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Administration of H1 and H2 antagonists for chemoprophylaxis: a double-blind, placebo-controlled study in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Skin concentrations of H1-receptor antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Treatment of urticaria. An evidence-based evaluation of antihistamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

Peripheral and central mediators of itch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

Nalmefene and pruritus

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

Prolonged relief of intractable pruritus in primary sclerosing cholangitis by plasmapheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

Treatment of urticaria and angioedema: Low-sedating H1-type antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901434-1

7 January 2021

Antihistamines versus aspirin for itching in late pregnancy.

1 reference

12 January 2024

https://opencitations.net/index/api/v1/citations/10.1002/14651858.CD000027

Identifiers

DOI

10.1016/S0002-9343(02)01434-1

1 reference

https://doi.org/10.1016%2FS0002-9343%2802%2901434-1